Avalyn Pharma
AVLN · NASDAQ
$24.63+$1.30 (+5.57%)TodayMarket closed ·
Prev close $23.33
Who owns AVLN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 62.3% of AVLN’s shares.
- Fidelity Management & Research Company LLC13.1%
- Novo Holdings A/S8.8%
- SR One Capital Management, LP7.5%
- Perceptive Advisors LLC6.0%
- Next 6 largest institutions27.0%
- All other shareholders37.7%
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Management & Research Company LLC | 5.79M | 13.07% |
| Novo Holdings A/S | 3.88M | 8.76% |
| SR One Capital Management, LP | 3.31M | 7.46% |
| Perceptive Advisors LLC | 2.68M | 6.03% |
| Montanova Capital, LLC | 2.50M | 5.65% |
| Norwest Venture Partners | 2.27M | 5.12% |
| Wellington Management Company, LLP | 2.20M | 4.97% |
| T. Rowe Price Associates, Inc. | 1.71M | 3.86% |
| Catalio Capital Management, LP | 1.68M | 3.78% |
| T. Rowe Price Investment Management, Inc. | 1.60M | 3.62% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Small Cap Growth Fund | 1.23M | 2.78% |
| Fidelity Small Cap Growth K6 Fund | 627.19K | 1.41% |
| Vanguard Total Stock Market Index Fund | 534.44K | 1.21% |
| iShares Russell 2000 ETF | 433.59K | 0.98% |
| T. Rowe Price Small Cap Stock Fund | 415.61K | 0.94% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $25.00M (4 trades) of AVLN on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Meyer Robert J. | Award | 31.18K | — |
| FMR LLC | Other | 377.95K | — |
| FMR LLC | Other | 225.84K | — |
| FMR LLC | Other | 872.87K | — |
| FMR LLC | Other | 80.29K | — |
| FMR LLC | Other | 727.59K | — |
| FMR LLC | Other | 377.95K | — |
| FMR LLC | Other | 225.84K | — |
| FMR LLC | Other | 872.87K | — |
| FMR LLC | Other | 80.29K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.52M
- Days to cover
- 8.52
- % of shares outstanding
- 5.68%
- Average daily volume
- 295.21K
- Change since last report
- +20.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.